Potency preservation following stereotactic body radiation therapy for prostate cancer.

about

Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.

P2860

Q37175207-8FB8BA74-74D1-442F-8316-A72A3212680E

P2860

Potency preservation following stereotactic body radiation therapy for prostate cancer.

Item

http://www.wikidata.org/entity/Q38158080

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Potency preservation following stereotactic body radiation therapy for prostate cancer.

@en

type

Item

label

Potency preservation following stereotactic body radiation therapy for prostate cancer.

@en

prefLabel

Potency preservation following stereotactic body radiation therapy for prostate cancer.

@en

P1476

Potency preservation following stereotactic body radiation therapy for prostate cancer.

@en

P2093

Aditi Bhagat

http://www.w3.org/2001/XMLSchema#string

Anatoly Dritschilo

http://www.w3.org/2001/XMLSchema#string

Brian T Collins

http://www.w3.org/2001/XMLSchema#string

Deepak Kumar

http://www.w3.org/2001/XMLSchema#string

Gaurav Bandi

http://www.w3.org/2001/XMLSchema#string

Gerald P Batipps

http://www.w3.org/2001/XMLSchema#string

Henry C Wright

http://www.w3.org/2001/XMLSchema#string

John H Lynch

http://www.w3.org/2001/XMLSchema#string

John Pahira

http://www.w3.org/2001/XMLSchema#string

Joy S Kim

http://www.w3.org/2001/XMLSchema#string

P2860

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study.

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.

Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer.

Short-term sexual function after prostate brachytherapy.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma.

Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.

P2888

1748-717x-8-256

P304

256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-8-256

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014387691

http://www.w3.org/2001/XMLSchema#string

P698

24180317

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4228383

http://www.w3.org/2001/XMLSchema#string

Potency preservation following stereotactic body radiation therapy for prostate cancer.

about

P2860

P2860

Potency preservation following stereotactic body radiation therapy for prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932